Daltontx
3 known investors
DaltonTx builds an AI-enabled cloud platform for drug discovery, covering the full lifecycle from data ingestion and model training to molecule generation and experiment prioritisation for both biologics and small molecules. It serves pharma, biotech, and CROs, positioning itself as R&D infrastructure that combines human scientific expertise with machine intelligence.
Founders & leadership
DG
Dr. Garry PairaudeauCEO and Co-Founder
DA
Dr. Anthony BradleyCSO and Co-Founder
PC
Professor Charlotte Deane MBECAIO and Co-Founder
AR
Adrian RossallCTO and Co-Founder